Gut Health

Microbiota Transplant

South America's first Microbiota Transplant bank. Restoring gut health through evidence-based microbiome transplantation, in collaboration with Biomedical Technologies SAC.

Start Your Application See Conditions We Treat

Conditions We Treat

Each protocol is backed by clinical evidence and tailored to the patient.

Recurrent C. difficile Infection

Strong Evidence
  • 3 days
  • 87–93% cure rate

Severe/Fulminant C. difficile

Strong Evidence
  • 5–7 days
  • ~92% colectomy avoidance

Autism (ASD) + GI Dysbiosis

Moderate Evidence
  • 5 or 10 days
  • 35–80% GI improvement

Ulcerative Colitis

Moderate Evidence
  • 10 days
  • 25–55% response rate

Irritable Bowel Syndrome (IBS)

Moderate Evidence
  • 5 days
  • 50–75% response rate

Small Intestinal Bacterial Overgrowth (SIBO)

Emerging Evidence
  • 5 days
  • 50–70% improvement

Hepatic Encephalopathy

Moderate Evidence
  • 4 days
  • 50–100% recurrence reduction

Obesity & Metabolic Syndrome

Moderate Evidence
  • 9 days
  • 20–30% HOMA-IR reduction

What is Microbiota Transplantation?

A clinically supervised treatment that transfers a healthy microbial ecosystem to patients with gut dysbiosis.

First Microbiota Transplant Bank in South America

ARDIG operates the first dedicated Microbiota Transplant bank in South America, using multi-donor pooled material screened for over 200 markers, stored at -80°C, and processed under strict anaerobic conditions.

Rigorous Donor Screening

Every donor undergoes comprehensive screening with over 200 biomarkers including infectious, metabolic, and microbiome composition panels. Multi-donor pooling maximizes microbial diversity.

Protocol-Driven Treatment

Each condition has a physician-designed protocol specifying the number of sessions, duration, and monitoring schedule based on the latest clinical evidence.

ARDIG + Biomedical Technologies SAC

HumanBiome

ARDIG, in collaboration with Biomedical Technologies SAC, operates the first dedicated Microbiota Transplant bank in South America. Our HumanBiome line is processed under rigorous quality standards, using multi-donor pooled material screened for over 200 biomarkers, stored at -80°C under strict anaerobic conditions.

  • Multi-donor pooled material for maximum microbial diversity
  • Over 200 biomarkers screened per donor
  • Anaerobic processing preserving obligate anaerobes
  • Full chain-of-custody documentation
  • 24-month shelf life at -80°C

The First Dedicated Microbiota Transplant Bank in South America

ARDIG has established the first dedicated Microbiota Transplant bank in South America, based in Lima, Peru. Our facility enables rapid availability of screened transplant material for patients across the region.

Start Your Application

How the Treatment Process Works

From application to follow-up, every step is guided by our medical team.

1

Submit Your Application

Complete the pre-eligibility form online. Our medical team reviews each application and contacts you within 48–72 hours.

2

Medical Evaluation

A physician reviews your medical history, confirms your indication, and selects the appropriate protocol and tier for your condition.

3

Travel to Lima, Peru

Treatment is performed at our facility in Lima. Plan your stay based on your protocol duration (3–10 days depending on condition). Patients arrange their own travel and accommodation.

4

Treatment Protocol

Intestinal preparation on Day 0, followed by daily supervised treatment sessions. Each session takes approximately 30–60 minutes with monitoring.

5

Follow-Up & Monitoring

Post-treatment follow-up via telemedicine at weeks 2, 4, and 8, with in-person visits at months 6 and 12 to assess outcomes and determine if additional courses are needed.

Start Your Application

Learn More About Microbiota Transplantation

Watch our educational videos to learn how Microbiota Transplantation works and hear real patient stories.

Microbiota Transplant and Autism: What Does Current Science Say?

Microbiota Transplant and Autism: What Does Current Science Say?

A look at the latest scientific evidence on microbiota transplantation as a treatment approach for autism spectrum disorder.
Microbiota Transplant: The Science Behind a Revolutionary Treatment

Microbiota Transplant: The Science Behind a Revolutionary Treatment

Discover how microbiota transplantation works and the science that makes it a groundbreaking medical treatment.
See All Videos

Risks & Limitations

Transparency is a core ARDIG value. We believe every patient deserves to understand both the potential benefits and the limitations of any treatment.

General Risks

Common side effects include mild abdominal distension, flatulence, and transient diarrhea (2–5 days). In pediatric ASD patients, transient behavioral irritability in the first 48–72 hours is common and self-limiting. Patients with cirrhosis require close monitoring due to compromised immunity.

Current Limitations

Microbiota Transplantation is a treatment, not a cure. Response rates vary by condition and by individual. Some indications have emerging evidence only. For some conditions, repeated courses may be needed to maintain benefit. Our medical team will give you an honest assessment of expected outcomes for your specific case.

Results vary by patient. Regenerative medicine is an evolving field and outcomes cannot be guaranteed. Consult with our physicians for a realistic assessment.

FAQ

Microbiota Transplantation involves transferring a carefully prepared, multi-donor microbial ecosystem into a patient's intestine via rectal enema. The goal is to restore a healthy, diverse gut microbiome that can displace pathogenic bacteria and restore normal gut function.

Every donor undergoes comprehensive screening with over 200 biomarkers including infectious disease panels, metabolic markers, microbiome composition analysis, and a detailed health questionnaire. We use multi-donor pooling to maximize microbial diversity. All material is processed under anaerobic conditions and stored at -80°C.

Most patients report minimal discomfort. The procedure involves a rectal enema administered in the left lateral (Sims) position, followed by 30–60 minutes of rest. Sessions typically take under an hour. For pediatric patients, our team is experienced in ensuring comfort throughout.

Stay duration depends on your condition and protocol. Lighter protocols (C. difficile, SIBO, IBS) require 3–5 days, while intensive protocols (ASD, UC, metabolic) require 5–10 days. Plan to arrive the day before treatment begins. Patients arrange their own travel and accommodation.

It depends on your condition and response. For recurrent C. difficile, a single course achieves 87–93% cure. For other conditions, some patients benefit from a repeat course after 3–6 months. Your physician will evaluate your progress and recommend additional courses only if clinically indicated.

Complete our online pre-eligibility application form. It collects your medical history and relevant information needed for our physicians to evaluate your candidacy. All information is confidential and reviewed within 48–72 hours.

Reach us

We reply within 24 hours Your information is private and secure